A Study of LY3143753 and LY3185643 in Healthy Participants
NCT02342314
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
68
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
LY3143753 (Part A)
DRUG:
LY3185643 (Part B)
DRUG:
Placebo (Part A and Part B)
DRUG:
rGlucagon (Part B)
Sponsor
Eli Lilly and Company